LETROZOLE

Description

Lapatinib – Targeted Therapy for HER2-Positive Breast Cancer

Lapatinib is a prescription targeted cancer therapy that belongs to the class of tyrosine kinase inhibitors (TKIs). It is primarily used for the treatment of HER2-positive breast cancer, particularly in patients with advanced or metastatic disease. Lapatinib works by blocking the HER2 (ErbB2) and EGFR (ErbB1) receptors, preventing tumor cell growth and proliferation.

At Oncomed Pharmacy, we provide authentic Lapatinib tablets from trusted manufacturers, ensuring patients receive safe, effective, and high-quality targeted oncology medicines.

Key Features of Lapatinib

• Indications:

o Advanced or metastatic HER2-positive breast cancer (often in combination with capecitabine)

o HER2-positive breast cancer in combination with letrozole for postmenopausal women

• Formulation: Oral tablets, available in multiple strengths (commonly 250 mg).
• Mechanism of Action: Dual tyrosine kinase inhibitor that blocks HER2 and EGFR pathways, reducing tumor growth and survival.
• Patient Benefit: Effective targeted therapy for HER2-positive tumors, often used when other treatments (like trastuzumab) have failed.

Why Buy Lapatinib from Oncomed Pharmacy?

• 100% genuine and quality-tested targeted therapy.
• Affordable pricing with secure countrywide delivery.
• Available in multiple strengths for personalized dosing.
• Trusted global supplier specializing in oncology medicines for breast cancer treatment.

Uses of Lapatinib

• Standard therapy for HER2-positive metastatic breast cancer.
• Used in combination with capecitabine to delay cancer progression.
• In combination with letrozole, it provides dual HER2 and hormonal blockade in hormone receptor-positive, HER2-positive breast cancer.